Skip to content

Effects of a Multicomponent Exercise Program in Older Adults Undergoing Cancer Treatment: A Randomized Controlled Trial

Effects of a Multicomponent Exercise Program on Functional Capacity, Neuromuscular Parameters, Quality of Life, and Disease-Related Symptoms in Older Adults Undergoing Cancer Treatment: A Randomized, Controlled Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07565519
Enrollment
180
Registered
2026-05-04
Start date
2026-03-02
Completion date
2027-06-01
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Aging

Keywords

Aging, Neoplasia, Physical activity

Brief summary

This study aims to understand how a home-based exercise program can help improve strength, mobility, and quality of life in older adults receiving cancer treatment. Participants will be randomly divided into two groups: One group will follow a one-year multicomponent exercise program based on the ViviFrail model, done safely at home. The other group will continue with usual care. We will include men and women aged 60 or older treated at Hospital Conceição in Porto Alegre. Assessments will take place at the beginning and after 12, 24, and 48 weeks. We will measure walking speed, balance, muscle strength, and ask about quality of life, symptoms, and daily activity. The goal is to see whether home-based exercise can help older adults with cancer stay stronger, more independent, and feel better during treatment.

Detailed description

The main objective of this study is to identify and compare the effects of a one-year physical exercise program based on the ViviFrail model versus usual care on functional capacity, neuromuscular parameters, quality of life, and disease-related symptoms in older adults undergoing cancer treatment.

Interventions

Participants randomized to the intervention group will receive educational material about exercising during cancer treatment. In addition, they will receive a physical exercise passport based on the ViviFrail program (A, B, C, or D) according to their baseline assessment. The passport includes instructions and illustrations of each exercise, as well as details on the number of sets and repetitions, required equipment, and a training log. Furthermore, participants in the intervention group will have access to online materials, including videos demonstrating each exercise, and will attend a pre-scheduled in-person session at Hospital Conceição in Porto Alegre to address any questions.

Sponsors

Federal University of Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The person responsible for the randomization will not be one of the researchers involved in the assessments and will have no contact with the participants. Questionnaires and tests will be administered by evaluators blinded to the participants' group allocation.

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Men and women aged 60 years or older who are undergoing cancer treatment at Hospital Conceição in Porto Alegre, who have the cognitive ability to understand the exercises, are able to walk (even with assistance), and have medical clearance to participate in physical exercise will be included in the study. \-

Exclusion criteria

Participants who miss more than two assessments will be excluded. \-

Design outcomes

Primary

MeasureTime frameDescription
Gait abilityFrom enrollment and at 4, 12, 24 and 48 weeksTimed Up and Go test and the 6-meter gait speed test, following the recommendations of Izquierdo (2019)
Hand grip strengthFrom enrollment and at 4, 12, 24 and 48 weeksWill be measured using a Jamar Hydraulic Hand Dynamometer, following the guidelines of the American Society of Hand Therapists (MacDermid et al., 2015).
SPPB BatteryFrom enrollment and at 4, 12, 24 and 48 weeksSPPB tests: the five-times sit-to-stand test from a standard chair, 4-meter gait speed test, and balance tests in bipodal, semi-tandem, and tandem positions. (Izquierdo, 2019)
Peak power on seat to standing movementFrom enrollment and at 4, 12, 24 and 48 weeksusing a linear displacement transducer (encoder) during the three-times sit-to-stand test from a standard chair. The participant will start seated, with their hands resting on their knees, and the encoder will be attached to the right wrist using a Velcro strap. At the command "go," the participant will be instructed to stand up from the chair as quickly as possible and sit back down, repeating the movement three times.
number of hospitalizationsFrom enrollment and at the end of the study, in 48 weeksStandardized questionnaire
Treatment toxicityFrom enrollment and at the end of the study, in 48 weeksNCI-PRO-CTCAE ITEMS - Portuguese for Brazil, following the recommendations of Pires et al. (2022).
Mortality rateFrom enrollment and at the end of the study, in 48 weeksStandardized questionnaire
Number of fallsFrom enrollment and at 4, 12, 24 and 48 weeksStandardized questionnaire

Secondary

MeasureTime frameDescription
Physical activity levelFrom enrollment and at the end of the study, in 48 weeksPhysical activity level will be assessed using the Baecke Physical Activity Questionnaire (Simões, 2009), which refers to the 12 months prior to the study and is divided into questions related to daily living activities, sports activities, and leisure activities. Participants will be classified as low physical activity (≤ 9.11 points), moderately active (9.12 to 16.17 points), or highly active (≥ 16.18 points).
Vastus lateralis muscle thicknessFrom enrollment and at 4, 12, 24 and 48 weeksMuscle thickness will be assessed using ultrasonography (Nemio XG, Toshiba, Japan) of the vastus lateralis of the participants' right leg, following the recommendations of Pinto et al. (2015). Three images of the vastus lateralis will be collected at 30% of the distance from the lateral femoral epicondyle to the greater trochanter, along the patella. A tracing map on acetate will be produced to ensure greater precision in repeated measurements.
Vastus intermedius muscle thicknessFrom enrollment and at 4, 12, 24 and 48 weeksMuscle thickness will be assessed using ultrasonography (Nemio XG, Toshiba, Japan) of the vastus intermedius of the participants' right leg, following the recommendations of Pinto et al. (2015). Three images of the vastus intermedius will be collected at 50% of the distance from the lateral femoral epicondyle to the greater trochanter, along the midline of the patella. A tracing map on acetate will be produced to ensure greater precision in repeated measurements.
Rectus femoralis muscle thicknessFrom enrollment and at 4, 12, 24 and 48 weeksMuscle thickness will be assessed using ultrasonography (Nemio XG, Toshiba, Japan) of the rectus femoralis of the participants' right leg, following the recommendations of Pinto et al. (2015). Three images of the vastus intermedius will be collected at 50% of the distance from the lateral femoral epicondyle to the greater trochanter, along the midline of the patella. A tracing map on acetate will be produced to ensure greater precision in repeated measurements.
Quality of Life QuestionnarieFrom enrollment and at 4, 12, 24 and 48 weeksWill be assessed using the Nottingham Health Profile (NHP), which contains 38 items related to overall quality of life and produces a score ranging from 0 (best quality of life) to 38 (worst quality of life) (Teixeira-Salmela et al., 2004).
Fatigue related symptonsFrom enrollment and at 4, 12, 24 and 48 weeksBrief Fatigue Inventory for fatigue assessment (Mendoza et al., 1999)
Sleep qualityFrom enrollment and at 4, 12, 24 and 48 weeksPittsburgh Sleep Quality Index - BR for sleep quality assessment (Buysse et al., 1989)
Disease prognosisFrom enrollment and at 4, 12, 24 and 48 weeksKarnofsky Performance Scale Index for disease prognosis (Schag et al., 1984)

Countries

Brazil

Contacts

CONTACTEduardo L Cadore, PhD
edcadore@yahoo.com.br+555191193651
PRINCIPAL_INVESTIGATOREduardo L Cadore, PhD

Federal University of Rio Grande do Sul

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026